RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Clinical trial NCT00370331 · COMPLETED

Trial details

NCT number: NCT00370331
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2006-11-01
Primary completion: 2008-07-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.